Geneticure’s test obtains US patent to predict renal denervation response
American biotech Geneticure has received Patent No. 12,351,873 from the US Patent and Trademark Office (USPTO) for its genetic test …
-
-
FDA approves Dymicron’s study of cervical artificial disc
The US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) approval for Dymicron to initiate a pivotal …
-
Aqtual secures $31m to commercialise rheumatoid arthritis test
Precision medicine company Aqtual has secured $31m in a Series B financing round to progress its active chromatin cell-free DNA …
-
Neuros Medical raises $56m to commercialise nerve stimulation system in US
Neuros Medical has raised $56m in a Series D funding round to support the US commercialisation and further development of …
-
NICE issues positive guidance for pulsed field ablation in AF treatment
The UK's National Institute for Health and Care Excellence (NICE) has formally recommended the use of Pulsed Field Ablation (PFA) …
-
ClearNote Health’s pancreatic cancer test secures UKCA marking
ClearNote Health’s Avantect Pancreatic Cancer Test has secured the UK Conformity Assessed (UKCA) marking, signifying compliance with medical device regulations …
-
FDA grants 510(k) clearance for Exactech’s scapula reconstruction system
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Exactech’s Equinoxe scapula reconstruction system for treating acromial …
-
Trump’s 200% tariff threat could send shockwaves through pharma supply chains
US President Donald Trump's 200% tariff threat on the pharmaceutical industry is a "shock" that will reverberate through global supply …
-
MediView enrols first patient in XR90 study for soft tissue biopsy
MediView has announced the first patient enrolment in a multi-centre study to assess the procedural efficiency of its XR90 holographic …
-
Companion Spine to acquire Paradigm Spine assets from Xtant Medical
French-American spine pain-management surgery specialist Companion Spine has entered a definitive agreement to acquire the Coflex Interlaminar Stabilization device (Corflex), …
-
FDA clears Mendaera’s robotic system for ultrasound-guided needle placement
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Mendaera’s Focalist, a handheld robotic system designed to …
-
Medical Device Network Excellence Awards 2025: BVI Medical
BVI has been recognized with four awards in the 2025 Medical Device Network Excellence Awards for achievements in Innovation, Research …
-
Wired for precision: How thermocouple technology is powering oncology innovation
Ablation therapy treats cancer by applying extreme heat or cold directly to a tumour, destroying malignant cells with unprecedented accuracy. …
-
CorFlow Therapeutics to begin pivotal trial of CoFl system for heart attack care
CorFlow Therapeutics is set to initiate a pivotal trial of its CorFlow CoFl system across US hospitals for patients being …
-
Morphic Medical obtains CE mark for obesity treatment
Morphic Medical has obtained an EU CE mark for RESET, a device designed to target the underlying cause of obesity …
